Abstract
Drug content uniformity among individual dosage units of pharmaceutical products has received increasing attention over recent years. Sampling plans and specifications set forth in the official compendia to which the industry is bound are attribute plans based upon variables measurements. These plans do not efficiently utilize all of the information available to the analyst nor do they include provisions for quantifying the decisions in a probabilistic sense. The authors consider procedures for correcting these shortcomings through combining both unit weight and quantitative assay data into alternative statements of information content which could be useful in evaluating pharmaceutical quality. Areas requiring further theoretical development are outlined.
Keywords
Computer scienceQuality (philosophy)Set (abstract data type)Content (measure theory)Pharmaceutical industrySampling (signal processing)Probabilistic logicOperations researchData miningRisk analysis (engineering)MathematicsBusinessArtificial intelligenceBiotechnology
Affiliated Institutions
Related Publications
InteractionGraphNet: A Novel and Efficient Deep Graph Representation Learning Framework for Accurate Protein–Ligand Interaction Predictions
Accurate quantification of protein-ligand interactions remains a key challenge to structure-based drug design. However, traditional machine learning (ML)-based methods based on ...
PoseBusters: AI-based docking methods fail to generate physically valid poses or generalise to novel sequences
PoseBusters assesses molecular poses using steric and energetic criteria. We find that classical protein-ligand docking tools currently still outperform deep learning-based meth...
TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction
Abstract Illuminating interactions between proteins and small drug molecules is a longstanding challenge in the field of drug discovery. Despite the importance of understanding ...
Structure-based drug design with geometric deep learning
Structure-based drug design uses three-dimensional geometric information of macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric deep learn...
Publication Info
- Year
- 1971
- Type
- article
- Volume
- 3
- Issue
- 4
- Pages
- 170-178
- Citations
- 8
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
8
OpenAlex
1
Influential
7
CrossRef
Cite This
C. B. Sampson,
H. Latham Breunig
(1971).
Some Statistical Aspects of Pharmaceutical Content Uniformity.
Journal of Quality Technology
, 3
(4)
, 170-178.
https://doi.org/10.1080/00224065.1971.11980490
Identifiers
- DOI
- 10.1080/00224065.1971.11980490